Global Inhalation Anesthesia Market

Inhalation Anesthesia Market Size, Share, Growth Analysis, By Application (Maintenance, Induction), By Drug (Sevoflurane, Isoflurane), By End User (Hospitals, Ambulatory Surgical Centers,), By Region -Industry Forecast 2024-2031

Report ID: SQMIG35B2212 | Region: Global | Published Date: October, 2024
Pages: 200 | Tables: 89 | Figures: 67

Inhalation Anesthesia Market News

  • Sedana Medical AB, a medical technology company based in Sweden announced the launch of Sedaconda in February 2022. Sedaconda is a type of isoflurane inhalation anesthetic that was approved for use in European countries in 2021.
  • Sevoflurane and Isoflurane anesthetic products were acquired by Dechra Pharmaceuticals back in January 2022. The company overtook these products from Halocarbon Life Sciences and extended its market share in the global inhalation anesthesia market.
  • Dechra Pharmaceuticals, a company based in the United Kingdom announced its new strategic partnership with Respirair Global in April 2022. The move is expected to help Respirair expand its offering of anesthetics in the United States market by leveraging Dechra’s expertise in the business.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Inhalation Anesthesia Market was valued at USD 1.45 Billion in 2022 and is expected to rise from USD 1.58 Billion in 2023 to USD 3.15 Billion by 2031, at a CAGR of 9% during the forecast period (2024–2031).

Inhalation anesthesia companies should focus on launching new training programs to help address the lack of skilled anesthesiologists around the world. Mergers, partnerships, and acquisitions are also expected to emerge as preferred strategies for inhalation anesthesia companies looking to improve their overall market share. Developing eco-friendly inhalation anesthesia products will also be a major trend for new as well as leading inhalation anesthesia providers in the future. 'Halocarbon Products Corporation', 'Sandoz International GmbH', 'Fresenius Kabi AG', 'AbbVie Inc.', 'Baxter International Inc.', 'Hikma Pharmaceuticals PLC', 'Jiangsu Hengrui Medicine Co. Ltd', 'Lunan Pharmaceutical Group Co. Ltd', 'Merck KGaA', 'Piramal Enterprises Limited', 'Troikaa Pharmaceuticals Ltd.'

Rising Number of Surgical Procedures

Demand for Sustainable Anesthetic Agents: Inhalation anesthesia manufacturers can focus on the development of anesthetic agents that have no or minimal impact on the environment and are compliant with the modern sustainability mandates. This trend will help inhalation anesthesia companies stand out in the future.

North America is projected to account for a dominant share of the global inhalation anesthesia market. The presence of a developed healthcare infrastructure and growing volume of surgeries performed in this region are helping it led the global inhalation anesthesia demand outlook. High availability of advanced anesthetic products, growing healthcare expenditure, and increasing geriatric population are also expected to promote inhalation anesthesia market development in this region. The United States and Canada are forecasted to be the top markets for inhalation anesthesia providers in this region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Inhalation Anesthesia Market

Report ID: SQMIG35B2212

$5,300
BUY NOW GET FREE SAMPLE